Medications

FDA approves first-in-class treatment for myasthenia gravis

(HealthDay)—Vyvgart (efgartigimod), a neonatal Fc receptor blocker (FcRn), was approved to treat generalized myasthenia gravis in adults who test positive for the anti-acetylcholine receptor (AChR) antibody, the U.S. Food ...

Health

Air pollution – a neglected cause of death 

In 2015, around 4.5 million people died prematurely from diseases attributed to ambient air pollution, including 237,000 children under the age of five from respiratory infections. This is the result of a study published ...

Diseases, Conditions, Syndromes

Protective immunity to seasonal coronaviruses may be short-lasting

The duration of protective immunity against SARS-CoV-2 may be short-lived, suggests a study investigating immunity to four other, similar coronaviruses. The findings from a case study of ten healthy subjects monitored over ...

Health

Probiotics have slight preventive effect on colds

Taking probiotics seems to provide both children and adults with a mild degree of protection against many upper respiratory tract infections including the common cold, according to a new systematic review. People who consume ...

Diseases, Conditions, Syndromes

New nasal vaccine strategy could improve COVID-19 protection

Researchers from the Centenary Institute and the University of Sydney have developed a new nasal vaccination strategy that induces potent lung immunity and protection against the SARS-CoV-2 coronavirus.

Diseases, Conditions, Syndromes

Increased risk of developing asthma by age of 3 after cesarean section

A new study supports previous findings that children delivered by cesarean section have an increased risk of developing asthma. The study from the Norwegian Mother and Child Cohort Study (MoBa) suggests that children delivered ...

page 4 from 33